IMARC Group, a leading market research company, has recently releases report titled “Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global aptamers market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the aptamers market?
The global aptamers market size reached US$ 2.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.5 Billion by 2028, exhibiting a growth rate (CAGR) of 20.6% during 2023-2028.
What is the aptamers?
Aptamers are short, single-stranded nucleic acids (DNA or RNA) or peptide molecules that can bind with high specificity and affinity to various target molecules, such as proteins, small molecules, and even whole cells. They are often referred to as "chemical antibodies" due to their functional similarity to antibodies in terms of target recognition and binding.
Aptamers are created from a process named the systematic evolution of ligands by exponential enrichment (SELEX). SELEX involves iterative rounds of selection, amplification, and enrichment to identify aptamers with high binding affinity and specificity for a particular target molecule. During each round, a large library of random oligonucleotides or peptides is exposed to the target, and the sequences that bind most strongly are selectively amplified and used as the starting pool for the next round. This process is repeated several times until aptamers with the desired binding characteristics are obtained.
Aptamers Market Trends:
The increasing demand for targeted therapies represents a significant factor driving the market growth across the globe. This, coupled with, the rising potential for enhanced efficacy and reduced side effects, is driving the demand for aptamers in the pharmaceutical industry. In line with this, the awareness regarding the advantages of aptamers over traditional antibodies, such as easier synthesis, modification, and large-scale production is contributing to the growth of the aptamers market.
The market is also driven by the widespread adoption of aptamers across various industries, including healthcare, diagnostics, biotechnology, and research. Other factors, such as the increasing investment in research and development (R&D), the rising need for point-of-care (POC) diagnostics, and a favorable regulatory environment, are creating a positive outlook for the market further across the globe.
Request to Get the Sample Report: https://www.imarcgroup.com/aptamers-market/requestsample
Aptamers Market 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
Who are the key players operating in the industry?
Aptamers Key Companies:
- Aptagen LLC
- Aptamer Group
- Aptamer Sciences Inc.
- Aptus Biotech S.L.
- Base Pair Biotechnologies Inc.
- IBA GmbH
- Kaneka Eurogentec S.A. (Kaneka Corporation)
- NeoVentures Biotechnology Inc.
- NOXXON Pharma
- SomaLogic Inc.
- TriLink BioTechnologies LLC
- Vivonics Inc.
Explore Full Report Description At: https://www.imarcgroup.com/aptamers-market
Report Segmentation:
The report has segmented the global aptamers market on the basis of type, application and region.
Breakup by Type:
- Nucleic Acid
- Peptide
Breakup by Application:
- Diagnostics
- Therapeutics
- Research and Developments
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
